On March 10, 2022, China NMPA issued an announcement, answering frequently asked questions about cosmetic ingredient safety information, efficacy claim evaluation and sample retention. With the aim to further standardize the supervision and administration of cosmetics, as well as to protect the legitimate rights and interests of consumers, China National Medical Products Administration (NMPA) has sorted out the questions of great concern to the cosmetics industry, and answered them in an announcement released on March 10, 2022. 1 Q1. How to correctly submit cosmetic ingredient safety information when applying for registration or notification? A1: According to Cosmetic Supervision and Administration Regulation (CSAR), Administrative Measures on Cosmetics Registration and Notification, as well as Safety and Technical Standards for Cosmetics 2015, cosmetic registrants and notifiers shall carry out safety risk assessment on cosmetic ingredients, and submit the safety information of ingredients used in product formula during the registration and notification. With the launch of the cosmetic ingredients safety information…